Navigation Links
UW launches study testing adult stem cells for heart damage repair

study that involves adult subjects who have severe coronary artery disease, are currently on maximal medical therapy and are not suitable candidates for conventional procedures (such as angioplasty, stents, or coronary artery bypass surgery) to improve blood flow to the heart.

UW Hospital and Clinics is one of 15-20 research sites nationwide participating in the study, which is sponsored by the Cellular Therapies business unit of Baxter Healthcare Corporation. Baxter technology is used to select the subject's own CD34+ stem cells that are under investigation in this trial.

The first step in the ACT34-CMI trial is to establish the baseline of how often the study subjects have chest pain related to their heart disease and the severity of the pain. Next, all subjects receive a series of needle shots, typically delivered under the skin in the arm, thigh or abdomen of a commercially produced protein (granulocyte colony stimulating factor). The protein helps to release blood-forming CD34+ cells from a subject's bone marrow into the bloodstream.

Then, investigators use a cell separation system to remove from the subject's bloodstream a mix of cells containing the stem cells. When this process, known as apheresis, is complete, technologists further process the collected stem cells to select the CD34+ stem cells for use in this investigational therapy.

UW Health interventional cardiologists then "map" the heart with a catheter-based, non-surgical system to identify regions of the heart as targets for cell delivery. The researchers then use a special investigational catheter system to deliver either CD34+ cells or placebo into areas of the heart that have poor blood flow. Subjects are randomly selected to receive either one of two dosing levels of CD34+ stem cells, or placebo. Subjects will receive follow-up examinations for 12 months following the investigative procedure.

"The initial results from Phase I of the trial we
'"/>

Source:University of Wisconsin-Madison


Page: 1 2 3

Related biology news :

1. UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders
2. UNC launches study of liver injury caused by drugs
3. DOE JGI launches IMG public online microbial genome data clearinghouse
4. NIEHS launches website with information for assessing environmental hazards from Hurricane Katrina
5. NIH launches comprehensive effort to explore cancer genomics
6. Virginia Bioinformatics Institutes launches microbial database
7. BioMed Central launches Biology Direct
8. Protein structure initiative launches new resources for the scientific community
9. NIH neuroscience microarray consortium launches high-throughput genotyping services
10. ESA launches new project to protect biodiversity
11. Africas first large-scale HIV vaccine study launches
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: launches study testing adult stem cells for heart damage repair

(Date:5/22/2013)... 22, 2013. Plastic additives known as phthalates (pronounced ... They turn up in flooring, plastic cups, beach ... Centers for Disease Control and Preventionthe bodies of ... come under increasing scrutiny. A growing collection of ... leech from packaging and mix with food) may ...
(Date:5/21/2013)... the nation,s land and water resources could likely support ... 25 billion gallons of algae-based fuel a year in ... , The findings come from an in-depth look at ... significant amounts of algae in large, specially built shallow ... issue of Environmental Science and Technology , published ...
(Date:5/21/2013)... Cancers of all types become most deadly when they ... has reached this stage, it becomes very difficult for ... can develop. Now, researchers at the University of Missouri ... target lymphoma tumor cells wherever they may be in ... in the MU College of Veterinary Medicine, says being ...
Breaking Biology News(10 mins):Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4MU researchers develop radioactive nanoparticles that target cancer cells 2
... of radiation based on verified scientific facts will be available ... The official kick-off meeting of the Community project ULICE ... Union is supporting with nearly 10 million euros, was held ... Therapy of the Heidelberg University Hospital. This consortium consists of ...
... the U.S. population is afflicted with an autoimmune ... chronic and require life-long care. Moreover, different autoimmune ... are caused by disruptions in common biological pathways. ... pathways, The Jackson Laboratory has published "Pathways to ...
... at UT Southwestern Medical Center have eliminated non-small cell ... drug called BEZ235 in combination with low-dose radiation. ... Cancer Research , UT Southwestern researchers found that ... of tumor cells with otherwise nontoxic radiation, the drug ...
Cached Biology News:Patients in Europe benefit from new radiation therapy 2Patients in Europe benefit from new radiation therapy 3UT Southwestern researchers use drug-radiation combo to eradicate lung cancer 2
(Date:5/23/2013)... Toronto, Canada (PRWEB) May 23, 2013 ... subjects, it is critical to adhere to principles ... protection (HSP). , Esteemed speaker Dr. Jeremy Lim, ... the audience: , ,     Understand the ... Clinical Practice (GCP) and additional regulations for the ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 ... ancestry tracing for people of African descent, today ... product offering. For people of all races, myDNAmix ... from five distinct populations: Indigenous Americas (Native American), ... India Subcontinent. , Originally launched in ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Watlow®, ... of complete thermal systems, recently introduced its new ... years of experience in designing and manufacturing industrial ... of products to serve diverse customer needs. , ... featured at the beginning of the book. These ...
(Date:5/22/2013)... Oven Industries announces the new 5R1-1400 ... via a PC through the TTL level UART Communication ... inches square can deliver up to 15 AMPS of ... solid state relay. Operator safety is achieved with 1KV ... and sensor input. Specifications: Input Voltage 85 to ...
Breaking Biology Technology:Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 3Watlow Introduces Its New Industrial Heater Catalog 2New AC Temperature Controller Announced by Oven Industries 2
... 3 Albert Liou, Corporate Vice,President and General ... PRXL ), a leading global,biopharmaceutical services provider, will ... Cost and Efficiency Savings in Running Clinical,Trials?" at ... and,Exhibition, to be held November 4 - 7, ...
... Altogen Biosystems (http://www.altogen.com ),announced launch of novel ... facilities for animal testing. Transfection is,one of the ... RNA molecules,into cells and tissues. This technique makes ... a gene or a small interfering RNA (siRNA),into ...
... N.J., Nov. 3 Arno Therapeutics,Inc. (OTC Bulletin Board: ... announced that Dr. Roger G. Berlin,Chief Executive Officer of ... Healthcare Conference on Monday, November 10, 2008 at 2:00 ... York Palace Hotel in New York City. Dr.,Berlin will ...
Cached Biology Technology:PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress 2PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress 3PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress 4Altogen Biosystems Launches New Nanoparticle-based In Vivo Transfection Reagent 2Arno Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference 2
Request Info...
RABBIT ANTI PORCINE CARBOXYPEPTIDASE B...
... Maker, 1. Modular system for large ... up to six lab-cast or precast ... with 18- or 24-cm Immobiline DryStrip ... gel cassettes.Innovative design simplifies loading and ...
albumin from bovine serum (BSA), 2,4-dinitrophenylated (DNP-BSA)...
Biology Products: